‘TGen One Health Collaborative’ uses holistic approach to connect human health and the environmentContinue reading
Author Archive: AZBio
National Cancer Institute awards Carlo Maley $10.8M grant
Carlo Maley, associate professor in the Biodesign Center for Biocomputing, Security and Society and director of the Arizona Cancer Evolution Center, was selected as a recipient of a $10.8M grant from the National Cancer Institute. The Breast Pre-Cancer Atlas will be an active repository for information about breast tumors, open to the scientific community to use for further analysis.Continue reading
INSYS Therapeutics Announces Results Of PK Study Assessing Proprietary Intranasal Naloxone Formulations Versus Intramuscular And Intravenous Naloxone For Opioid Overdose
INSYS Therapeutics, Inc. (NASDAQ: INSY), announced om November 1, 2018 that a pharmacokinetic (PK) study (INS012-18-119) of its proprietary intranasal naloxone spray formulations for the treatment of opioid overdose showed a distinctive PK profile compared to the current standards of intramuscular (IM) and intravenous (IV) administration of naloxone.
Honoring Our AZBio Veterans – Veterans Day 2018
Each Year AZBio extends an opportunity to all member companies to tell us about the veterans on their team. This video is our tribute to them and to all who have served. Continue reading
Jill German named Head of Roche Tissue Diagnostics
Jill German has been named Head of Roche Tissue Diagnostics, an innovator of tissue-based diagnostic solutions for patients worldwide. Located in Tucson, Arizona, Roche Tissue Diagnostics is the leading global supplier of cancer diagnostic systems to the pathology market, providing more than 250 cancer tests and associated instruments. She succeeds Ann Costello, who has taken on a new leadership position with Roche in Rotkreuz, Switzerland.Continue reading
Symple Surgical Secures NIH Grant & Angel Investment
One of Moonshot at NACET’s first business incubator and accelerator clients, Symple Surgical, Inc. (SSI), is graduating from the entrepreneurial program and relocating to Flagstaff Airport Airpark after securing significant grants and angel investment funds.Continue reading
City of Hope, TGen announce letter of intent to build cell therapy manufacturing facility in Phoenix
The move would enable the organizations to meet a demand for clinical cell therapies that is expected to grow 42 percent annually over the next decadeContinue reading